Laboratory of Parasitic Diseases,
National Institute of Allergy and Infectious Diseases,
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases
David L. Sacks has not added Biography.
If you are David L. Sacks and would like to personalize this page please email our Author Liaison for assistance.
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major.
The Journal of experimental medicine Oct, 1997 | Pubmed ID: 9314562
Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity.
The Journal of experimental medicine Oct, 1998 | Pubmed ID: 9782133
Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis.
The Journal of experimental medicine Nov, 1998 | Pubmed ID: 9815271
The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2000 | Pubmed ID: 10890924
Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.
The Journal of experimental medicine Aug, 2001 | Pubmed ID: 11489952
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure.
The Journal of experimental medicine Nov, 2001 | Pubmed ID: 11714756
Vaccination with heat-killed leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against leishmania major infection.
The Journal of experimental medicine Jun, 2002 | Pubmed ID: 12070284
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.
Nature Dec, 2002 | Pubmed ID: 12466842
Immunological and pathological evaluation of rhesus macaques infected with Leishmania major.
Experimental parasitology Mar-Apr, 2003 | Pubmed ID: 12880593
Coinjection with CpG-containing immunostimulatory oligodeoxynucleotides reduces the pathogenicity of a live vaccine against cutaneous Leishmaniasis but maintains its potency and durability.
Infection and immunity Sep, 2003 | Pubmed ID: 12933855
Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
Journal of immunology (Baltimore, Md. : 1950) Mar, 2005 | Pubmed ID: 15728505
Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection.
Infection and immunity Aug, 2005 | Pubmed ID: 16040984
Prevention and treatment of cutaneous leishmaniasis in primates by using synthetic type D/A oligodeoxynucleotides expressing CpG motifs.
Infection and immunity Aug, 2005 | Pubmed ID: 16041009
Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
Infection and immunity Oct, 2005 | Pubmed ID: 16177338
A Leishmania amazonensis ZIP family iron transporter is essential for parasite replication within macrophage phagolysosomes.
The Journal of experimental medicine Oct, 2006 | Pubmed ID: 17000865
Uninfected mosquito bites confer protection against infection with malaria parasites.
Infection and immunity May, 2007 | Pubmed ID: 17339356
Vector transmission of leishmania abrogates vaccine-induced protective immunity.
PLoS pathogens Jun, 2009 | Pubmed ID: 19543375
The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis.
Cellular microbiology Sep, 2009 | Pubmed ID: 19545276
Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern.
PLoS pathogens , 2010 | Pubmed ID: 21085609
Infection parameters in the sand fly vector that predict transmission of Leishmania major.
PLoS neglected tropical diseases Aug, 2011 | Pubmed ID: 21886852
Evaluation of recombinant Leishmania polyprotein plus glucopyranosyl lipid A stable emulsion vaccines against sand fly-transmitted Leishmania major in C57BL/6 mice.
Journal of immunology (Baltimore, Md. : 1950) Nov, 2012 | Pubmed ID: 23045616
Tracking antigen-specific CD4+ T cells throughout the course of chronic Leishmania major infection in resistant mice.
European journal of immunology Feb, 2013 | Pubmed ID: 23109292
Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.
Infection and immunity Jul, 2014 | Pubmed ID: 24733090
Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem.
Nature immunology May, 2014 | Pubmed ID: 24747701
Cross-species genetic exchange between visceral and cutaneous strains of Leishmania in the sand fly vector.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2014 | Pubmed ID: 25385616
Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re-infection.
PLoS pathogens Dec, 2014 | Pubmed ID: 25473946
Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum.
Journal of immunology (Baltimore, Md. : 1950) Oct, 2015 | Pubmed ID: 26371247
The Nlrp3 inflammasome, IL-1β, and neutrophil recruitment are required for susceptibility to a nonhealing strain of Leishmania major in C57BL/6 mice.
European journal of immunology Apr, 2016 | Pubmed ID: 26689285
The Transcriptome of Developmental Stages in Their Natural Sand Fly Vector.
mBio 04, 2017 | Pubmed ID: 28377524
Divergent roles for Ly6C+CCR2+CX3CR1+ inflammatory monocytes during primary or secondary infection of the skin with the intra-phagosomal pathogen Leishmania major.
PLoS pathogens Jun, 2017 | Pubmed ID: 28666021
Gene Expression in Is Regulated Predominantly by Gene Dosage.
mBio 09, 2017 | Pubmed ID: 28900023
NOX2-Derived Reactive Oxygen Species Control Inflammation during Infection by Mediating Infection-Induced Neutrophil Apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 01, 2018 | Pubmed ID: 29158417
Mannose receptor high, M2 dermal macrophages mediate nonhealing infection in a Th1 immune environment.
The Journal of experimental medicine 01, 2018 | Pubmed ID: 29247046
Inflammasomes and Leishmania: in good times or bad, in sickness or in health.
Current opinion in microbiology 12, 2019 | Pubmed ID: 31229882
CRISPR/Cas9 Mutagenesis in Phlebotomus papatasi: the Immune Deficiency Pathway Impacts Vector Competence for Leishmania major.
mBio 08, 2019 | Pubmed ID: 31455654
M2-like, dermal macrophages are maintained via IL-4/CCL24-mediated cooperative interaction with eosinophils in cutaneous leishmaniasis.
Science immunology 04, 2020 | Pubmed ID: 32276966
The Null Hypothesis of IFN-γ and Monocyte Function in Leishmaniasis.
Cell host & microbe 05, 2020 | Pubmed ID: 32407702
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유